AAL, based in Hong Kong, invests in growth capital opportunities in the People’s Republic of China, in the following sectors:

  • Consumer
  • Enterprise
  • Health Care

AAL looks for long term investment opportunities with appreciation potential.  AAL expects to hold investments for 3-7 years on average, and focuses on companies that want to independently grow to the point at which they are candidates to be publicly traded companies (via Initial Public Offering). Growth stage opportunities attractive to AAL typically have early revenue and are often profitable. AAL invests primarily into onshore enterprises that are, at the time of investment, already existing CJV (Contractual Joint Venture) or EJV (Equity Joint Venture) structures which allow for domestic China enterprises to receive foreign equity investment.

AAL’s objective is to provide capital and other non-financial value add services (such as managerial expertise, consulting, marketing strategy) in order to create significant value. AAL considers target companies that vie for local China stock market listing as attractive opportunities, such as the Shenzhen-based ChiNext stock exchange, the Shenzhen SME exchange, and the Shanghai stock exchange (A-share market).

The main focus of AAL is fundamental value investing as a leading and valuable partner alongside the existing shareholders and management team of target investment opportunities.